Lacosamide Adroiq الاتحاد الأوروبي - السلوفاكية - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lakosamid - epilepsie - antiepileptiká, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Topilex 50 mg سلوفاكيا - السلوفاكية - ŠÚKL (Štátny ústav pre kontrolu liečiv)

topilex 50 mg

g.l. pharma gmbh, rakúsko - topiramát - 21 - antiepileptica, anticonvulsiva

Topilex 100 mg سلوفاكيا - السلوفاكية - ŠÚKL (Štátny ústav pre kontrolu liečiv)

topilex 100 mg

g.l. pharma gmbh, rakúsko - topiramát - 21 - antiepileptica, anticonvulsiva

Clensia سلوفاكيا - السلوفاكية - ŠÚKL (Štátny ústav pre kontrolu liečiv)

clensia

alfasigma czech s.r.o., Česká republika - makrogol, kombinácie - 61 - laxantia